Skip to main content
Erschienen in: Supportive Care in Cancer 9/2014

01.09.2014 | Original Article

Assessing patient–caregiver communication in cancer—a psychometric validation of the Cancer Communication Assessment Tool (CCAT-PF) in a German sample

verfasst von: Markus W. Haun, Halina Sklenarova, Eva C. Winkler, Johannes Huber, Michael Thomas, Laura A. Siminoff, Michael Woll, Anette Brechtel, Wolfgang Herzog, Mechthild Hartmann

Erschienen in: Supportive Care in Cancer | Ausgabe 9/2014

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The recently introduced Cancer Communication Assessment Tool (CCAT-PF) measures congruence in patient–caregiver communication and was initially validated in lung cancer patients. Contributing to a greater proportion of the variance in the conflict scores, primary caregivers were hypothesized to experience greater stress. For a detailed understanding of conflicting communication patterns of cancer-affected families, our study aimed for psychometric validation of the CCAT-PF in a sample covering heterogeneous tumor entities.

Methods

Subsequent to a cross-sectional survey of 189 pairs of cancer patients (31 % gastrointestinal, 34 % lung, and 35 % urological) and their caregivers’ exploratory factor analysis with principal component condensation and varimax rotation was conducted (response rate, 74.2 %). Reliability and construct validity were assessed calculating Cronbach’s α and Pearson correlation coefficients for CCAT-P and CCAT-F scales and related constructs, respectively.

Results

Cancer-related communication according to the CCAT-PF can be subdivided into four factors including the scales Disclosure, Limitation of treatment, Family involvement in treatment decisions, and Continuing treatment. Reliability ranged from α = .51–.68. The Disclosure scale, describing poor cancer-related communication of the patient, was correlated with patient’s distress (QSC-R10: r = .30, p < .0001), unmet needs in several areas (SCNS-SF-34: r = .25–.32, p < .001), and negatively with social/family well-being (FACT: r = −0.31, p < .0001). Higher scores on the scale were significantly associated with considerable decrements in emotional well-being especially for caregivers perceiving patients’ disclosure as problematic.

Conclusions

The Disclosure scale originating from the CCAT-PF emerged as a short, valid, and reliable stand-alone instrument for identifying conflicting communication in patient–caregiver–dyads at risk.
Literatur
1.
Zurück zum Zitat Lewis FM (2009) The family’s “stuck points” in adjusting to cancer. In: Holland JC, Breitbart WS, Jacobsen PB (eds) Psycho-Oncology. Oxford University, New York, pp 511–515 Lewis FM (2009) The family’s “stuck points” in adjusting to cancer. In: Holland JC, Breitbart WS, Jacobsen PB (eds) Psycho-Oncology. Oxford University, New York, pp 511–515
2.
Zurück zum Zitat Manne SL et al (1999) Spousal negative responses to cancer patients: the role of social restriction, spouse mood, and relationship satisfaction. J Consult Clin Psychol 67(3):352–361PubMedCrossRef Manne SL et al (1999) Spousal negative responses to cancer patients: the role of social restriction, spouse mood, and relationship satisfaction. J Consult Clin Psychol 67(3):352–361PubMedCrossRef
3.
Zurück zum Zitat Burns CM et al (2007) Fluctuating awareness of treatment goals among patients and their caregivers: a longitudinal study of a dynamic process. Support Care Cancer 15(2):187–196PubMedCrossRef Burns CM et al (2007) Fluctuating awareness of treatment goals among patients and their caregivers: a longitudinal study of a dynamic process. Support Care Cancer 15(2):187–196PubMedCrossRef
4.
Zurück zum Zitat Siminoff LA et al (2008) The Cancer Communication Assessment Tool for Patients and Families (CCAT-PF): a new measure. Psychooncology 17(12):1216–1224PubMedCentralPubMedCrossRef Siminoff LA et al (2008) The Cancer Communication Assessment Tool for Patients and Families (CCAT-PF): a new measure. Psychooncology 17(12):1216–1224PubMedCentralPubMedCrossRef
5.
Zurück zum Zitat Siminoff LA et al (2006) Measuring discord in treatment decision-making; progress toward development of a cancer communication and decision-making assessment tool. Psychooncology 15:528–540PubMedCrossRef Siminoff LA et al (2006) Measuring discord in treatment decision-making; progress toward development of a cancer communication and decision-making assessment tool. Psychooncology 15:528–540PubMedCrossRef
6.
Zurück zum Zitat Bonett DG (2002) Sample size requirements for testing and estimating coefficient alpha. J Educ Behav Stat 27(4):335–340CrossRef Bonett DG (2002) Sample size requirements for testing and estimating coefficient alpha. J Educ Behav Stat 27(4):335–340CrossRef
7.
Zurück zum Zitat Escobar Pinzon LC et al (2010) End-of-life care in Germany: study design, methods and first results of the EPACS study (Establishment of Hospice and Palliative Care Services in Germany). BMC Palliat Care 9:16PubMedCentralPubMedCrossRef Escobar Pinzon LC et al (2010) End-of-life care in Germany: study design, methods and first results of the EPACS study (Establishment of Hospice and Palliative Care Services in Germany). BMC Palliat Care 9:16PubMedCentralPubMedCrossRef
8.
Zurück zum Zitat Book K et al (2011) Distress screening in oncology—evaluation of the Questionnaire on Distress in Cancer Patients—Short Form (QSC-R10) in a German Sample. Psychooncology 20(3):287–293PubMedCrossRef Book K et al (2011) Distress screening in oncology—evaluation of the Questionnaire on Distress in Cancer Patients—Short Form (QSC-R10) in a German Sample. Psychooncology 20(3):287–293PubMedCrossRef
9.
Zurück zum Zitat Kroenke K et al (2009) An ultra-brief screening scale for anxiety and depression: the PHQ-4. Psychosomatics 50(6):613–621PubMed Kroenke K et al (2009) An ultra-brief screening scale for anxiety and depression: the PHQ-4. Psychosomatics 50(6):613–621PubMed
10.
Zurück zum Zitat Girgis A, Lambert S, Lecathelinais C (2011) The supportive care needs survey for partners and caregivers of cancer survivors: development and psychometric evaluation. Psychooncology 20(4):387–393PubMedCrossRef Girgis A, Lambert S, Lecathelinais C (2011) The supportive care needs survey for partners and caregivers of cancer survivors: development and psychometric evaluation. Psychooncology 20(4):387–393PubMedCrossRef
11.
Zurück zum Zitat Cella DF et al (1993) The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol 11(3):570–579PubMed Cella DF et al (1993) The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol 11(3):570–579PubMed
12.
Zurück zum Zitat Cella DF et al (1995) Reliability and validity of the Functional Assessment of Cancer Therapy-Lung (FACT-L) quality of life instrument. Lung Cancer 12(3):199–220PubMedCrossRef Cella DF et al (1995) Reliability and validity of the Functional Assessment of Cancer Therapy-Lung (FACT-L) quality of life instrument. Lung Cancer 12(3):199–220PubMedCrossRef
13.
14.
Zurück zum Zitat Nunnally JC, Bernstein IH (1994) Psychometric theory, 3rd edn. McGraw-Hill, New York Nunnally JC, Bernstein IH (1994) Psychometric theory, 3rd edn. McGraw-Hill, New York
15.
Zurück zum Zitat Fife BL et al (2013) Partner interdependence and coping with life-threatening illness: the impact on dyadic adjustment. J Fam Psychol 27(5):702–711PubMedCrossRef Fife BL et al (2013) Partner interdependence and coping with life-threatening illness: the impact on dyadic adjustment. J Fam Psychol 27(5):702–711PubMedCrossRef
16.
Zurück zum Zitat Kornblith AB et al (2006) Cancer-related communication between female patients and male partners scale: a pilot study. Psychooncology 15(9):780–794PubMedCrossRef Kornblith AB et al (2006) Cancer-related communication between female patients and male partners scale: a pilot study. Psychooncology 15(9):780–794PubMedCrossRef
17.
Zurück zum Zitat Lo C et al (2013) Couples facing advanced cancer: examination of an interdependent relational system. Psychooncology 22(10):2283–2290 Lo C et al (2013) Couples facing advanced cancer: examination of an interdependent relational system. Psychooncology 22(10):2283–2290
18.
Zurück zum Zitat Northouse LL et al (2013) Randomized clinical trial of a brief and extensive dyadic intervention for advanced cancer patients and their family caregivers. Psychooncology 22(3):555–563PubMedCentralPubMedCrossRef Northouse LL et al (2013) Randomized clinical trial of a brief and extensive dyadic intervention for advanced cancer patients and their family caregivers. Psychooncology 22(3):555–563PubMedCentralPubMedCrossRef
Metadaten
Titel
Assessing patient–caregiver communication in cancer—a psychometric validation of the Cancer Communication Assessment Tool (CCAT-PF) in a German sample
verfasst von
Markus W. Haun
Halina Sklenarova
Eva C. Winkler
Johannes Huber
Michael Thomas
Laura A. Siminoff
Michael Woll
Anette Brechtel
Wolfgang Herzog
Mechthild Hartmann
Publikationsdatum
01.09.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 9/2014
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-014-2241-0

Weitere Artikel der Ausgabe 9/2014

Supportive Care in Cancer 9/2014 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.